Trading Signals: SAGE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)(SAGE Therapeutics Inc)
| Market is closed on Sat. Jan. 13, 2024 | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | | Latest Price | $(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SAGE advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting SAGE price | SAGE will advance at least -0% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA. |